DSP to Acquire Boston Biomedical, US Bioventure Specializing in Oncology

March 1, 2012
Mr Masayo Tada, President of Dainippon Sumitomo Pharma Dainippon Sumitomo Pharma (DSP) announced on February 29 that it reached an agreement the same day to acquire all shares of Boston Biomedical Inc. (BBI), a US drug discovery venture that focuses...read more